Tumor grade 2 or 3, general grading system
MONDO:0024496A morphologic qualifier indicating that a neoplastic lesion is moderately to poorly differentiated.
Also known as: grade 2/3
1 clinical trial for this condition and its sub-types.
Follow this condition — get notified about new trials